@Tom_Babington1 @OlivePufa @FrogHarmless I think I understand your hypotheses but to make sure: 1) ApoB is atherogenic 2) Lifetime exposure to ApoB will raise CVD risk regardless of other changes In counterpoint, we have the effects of SGLT2is which incre
6,361 followers
125 followers
RT @DiscoStew66: Canagliflozin, an SGLT2 inhibitor, improved several cardiovascular risk factors in the CANVAS Program. It reduced HbA1c, b…
10,886 followers
Canagliflozin, an SGLT2 inhibitor, improved several cardiovascular risk factors in the CANVAS Program. It reduced HbA1c, body weight, blood pressure, and increased HDL and LDL. But be wary of LCHF because your LDL might rise... 🤔 https://t.co/V9lT0a5KZ9
384 followers
RT @DiscoStew66: Canagliflozin (SGLT2 Inhibitor) Reduces HBA1C Reduces body weight Reduces blood pressure Increases HDL Increases LDL LCH…